Jacqueline Kraveka to Maximum Tolerated Dose
This is a "connection" page, showing publications Jacqueline Kraveka has written about Maximum Tolerated Dose.
Connection Strength
0.089
-
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma. Clin Cancer Res. 2022 09 15; 28(18):3950-3957.
Score: 0.055
-
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma. Pediatr Blood Cancer. 2016 Jan; 63(1):39-46.
Score: 0.034